Abstract: The subject invention pertains to a modified MC1R peptide ligand comprising a peptide that is a melanocortin 1 receptor (MC1R) ligand and a functionality or linker, such as a click functionality, for conjugation to a surface or agent. The modified MC1R peptide ligand can be coupled, e.g., via a click reaction with a complementary click functionality attached, to a moiety to form an MC1R-targeted agent. Drugs, contrast agents, polymers, particles, micelles, surfaces of larger structures, or other moieties can be targeted to the MC1R. The subject invention also pertains to a MC1R peptide ligand-micelle complex comprising a peptide that is a melanocortin 1 receptor ligand connected via a click reaction product to a micelle. The micelle is stable in vivo and can target melanoma tumor cells by association of the peptide ligand with the MC1R or the tumor and selectively provide a detectable and/or therapeutic agent (such as an imagable contrast agent and/or anti-cancer agent) selectively to the tumor cell.
Type:
Grant
Filed:
January 24, 2022
Date of Patent:
December 24, 2024
Assignees:
H. Lee Moffitt Cancer Center and Research Institute, Inc., Intezyne Technologies Inc., Arizona Board of Regents on Behalf of The University of Arizona, Board of Regents, The University of Texas System
Inventors:
Robert J. Gillies, David L. Morse, Natalie M. Barkey, Kevin N. Sill, Josef Vagner, Narges K. Tafreshi, Jonathan L. Sessler, Christian Preihs, Victor J. Hruby
Abstract: The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and micelles comprising the same. Compositions herein are useful for drug-delivery applications.
Abstract: The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and micelles comprising the same. Compositions herein are useful for drug-delivery applications.
Type:
Grant
Filed:
September 28, 2016
Date of Patent:
April 17, 2018
Assignee:
Intezyne Technologies, Inc.
Inventors:
Kevin Sill, Joseph Edward Semple, Tomas Vojkovsky
Abstract: The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and micelles comprising the same. Compositions herein are useful for drug-delivery applications.
Type:
Grant
Filed:
March 10, 2016
Date of Patent:
April 17, 2018
Assignee:
Intezyne Technologies, Inc.
Inventors:
Kevin Sill, Tomas Vojkovsky, Adam Carie, Joseph Edward Semple, Hooshmand Sheshbaradaran
Abstract: The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and micelles comprising the same. Compositions herein are useful for drug-delivery applications.
Type:
Grant
Filed:
April 23, 2015
Date of Patent:
November 22, 2016
Assignee:
Intezyne Technologies, Inc.
Inventors:
Kevin Sill, Tomas Vojkovsky, Adam Carie
Abstract: The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and micelles comprising the same. Compositions herein are useful for drug-delivery applications.
Type:
Grant
Filed:
March 15, 2013
Date of Patent:
July 14, 2015
Assignee:
Intezyne Technologies, Inc.
Inventors:
Kevin Sill, Tomas Vojkovsky, Adam Carie
Abstract: The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and micelles comprising the same.
Type:
Grant
Filed:
September 1, 2010
Date of Patent:
March 17, 2015
Assignee:
Intezyne Technologies, Inc.
Inventors:
Kevin N. Sill, Habib Skaff, Kurt Breitenkamp
Abstract: The present invention provides a methodology for transfecting cells in vitro. In particular, cationic polymers and polynucleotide containing polyplexes comprising such polymers are provided.
Abstract: The present invention provides a methodology for transfecting cells in vitro. In particular, cationic polymers and polynucleotide containing polyplexes comprising such polymers are provided.
Abstract: The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and micelles comprising the same. Compositions herein are useful for drug-delivery applications.
Abstract: The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and micelles comprising the same.
Type:
Grant
Filed:
December 19, 2012
Date of Patent:
July 15, 2014
Assignee:
Intezyne Technologies, Inc.
Inventors:
Kurt Breitenkamp, Kevin N. Sill, Habib Skaff, Rebecca Breitenkamp
Abstract: The present invention provides micelles having a polynucleotide encapsulated therein, the micelle comprising copolymers comprising hydrophobic moieties in a cationic complexing block. The invention further provides methods of preparing and using said micelles, and compositions thereof.
Type:
Grant
Filed:
August 21, 2012
Date of Patent:
June 10, 2014
Assignee:
Intezyne Technologies, Inc.
Inventors:
Janni Mirosevich, Gregoire Cardoen, Kevin N. Sill, Habib Skaff
Abstract: The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and micelles comprising the same. Compositions herein are useful for drug-delivery applications.
Abstract: The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and micelles comprising the same. Compositions herein are useful for drug-delivery applications.
Abstract: The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and micelles comprising the same. Compositions herein are useful for drug-delivery applications.
Abstract: The present invention provides micelles having an anthracycline encapsulated therein, the micelles comprising a multiblock copolymer. The invention further provides methods of preparing and using said micelles, and compositions thereof.
Type:
Grant
Filed:
July 25, 2013
Date of Patent:
January 14, 2014
Assignee:
Intezyne Technologies, Inc.
Inventors:
Kevin N. Sill, Habib Skaff, Jonathan Rios-Doris
Abstract: The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and micelles comprising the same. Compositions herein are useful for drug-delivery applications.
Abstract: The present invention provides bifunctional polymers, methods of preparing the same, and intermediates thereto. These compounds are useful in a variety of applications including the PEGylation of biologically active molecules. The invention also provides methods of using said compounds and compositions thereof.
Type:
Grant
Filed:
May 14, 2012
Date of Patent:
December 17, 2013
Assignee:
Intezyne Technologies, Inc.
Inventors:
Kurt Breitenkamp, Kevin Sill, Habib Skaff